Gonorrhoea surveillance study maps antibiotic resistance across Europe

May 15, 2018, Wellcome Trust Sanger Institute
Credit: CDC

The first European-wide genomic survey of gonorrhoea has mapped antibiotic resistance in this sexually transmitted disease throughout the continent. Researchers at The Centre for Genomic Pathogen Surveillance (CGPS), the Wellcome Sanger Institute, European Centre for Disease Control, and their collaborators also showed that using DNA sequencing data they could accurately determine antibiotic resistance and identify incorrect laboratory test results. This genomic approach could one day help doctors prescribe the most effective antibiotics for each region.

Reported in The Lancet Infectious Diseases, the study has also established an open genomic database of . The new resource will support real-time ongoing of gonorrhoea worldwide, which public health officials could use to monitor which of gonorrhoea are present globally and where new antibiotic resistance is emerging.

Gonorrhoea is the second most prevalent bacterial sexually transmitted infection (STI) globally and is caused by the bacterium Neisseria gonorrhoeae. The WHO estimates that gonorrhoea infects 88 million people globally each year. Amongst other complications, it can cause pelvic inflammatory disease and infertility if left untreated, and in some cases leads to life-threatening complications such as meningitis. Transmitted during unprotected sex, many strains of gonorrhoea are now difficult to treat due to the rise in antibiotic resistance.

To understand the extent of multidrug resistant strains and determine the best method for surveillance, the researchers studied 1054 samples of N. gonorrhoeae collected from 20 countries across Europe in 2013. Each sample was tested locally for type and antibiotic sensitivity, and was sent to a central laboratory for DNA extraction. The DNA was then sequenced and the data analysed at the Centre for Genomic Pathogen Surveillance and made accessible via their online platform, creating the first European-wide database of gonorrhoea.

The scientists discovered that using genomic data allowed them to identify clinically important, antibiotic resistant strains much more accurately than existing typing techniques, and to identify incorrect laboratory antibiotic resistance results.

Prof David Aanensen, a corresponding author on the paper and Director of The Centre for Genomic Pathogen Surveillance, Wellcome Sanger Institute, said: "Ours is the most comprehensive, structured genomic study of gonorrhoea to date, and data are available to healthcare workers worldwide to compare and view emerging strains of gonorrhoea. This combination of a new method with an accessible database and interpretation tools provides a genomic baseline of gonorrhoea strains and antibiotic resistance across Europe, which will strengthen real-time, surveillance of gonorrhoea.

Dr. Simon Harris, first author on the paper from the Wellcome Sanger Institute, said: "Our study shows that current methods for typing strains of gonorrhoea are not very effective for surveillance. We show that whole genome sequencing gives a true picture of where sensitive and resistant strains are circulating, which will allow doctors to quickly spot the emergence of new, antibiotic resistant gonorrhoea strains. A follow up study starting this year will show how the picture changes with time."

The web application is openly available online, and healthcare officials from around the world can use it and add their own genomic data. This will enable them to monitor the strains and antibiotic emerging in each geographic area. Ongoing surveillance would allow clinics to offer the most appropriate and help to delay the onset of further .

Dr. Gianfranco Spiteri, an author on the paper from the European Centre for Disease Prevention and Control which co-ordinates the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), said: "Drug-resistant bacteria are becoming a huge public health threat. To control them, we badly need new tools to identify and track new infections and antibiotic resistant strains. This new approach will allow European-wide genomic surveillance of gonorrhoea which directly influences infection control on a national level and helps to prevent gonorrhoea. This approach can also be expanded to other infections."

Explore further: First cases of extensively drug-resistant gonorrhea threaten future treatment

More information: The Lancet Infectious Diseases (2018). DOI: 10.1016/S1473-3099(18)30225-1

Related Stories

First cases of extensively drug-resistant gonorrhea threaten future treatment

May 14, 2018
Within a matter of weeks, three cases of gonorrhea that are resistant to the recommended first-line antibiotic treatment have been detected in Europe and Australia. At a time with limited alternatives to the current dual ...

Gonorrhoea strains across Europe becoming more susceptible to main treatment options

September 13, 2017
According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhoea infection have seen an encouraging ...

Encouraging decrease in certain antibiotic resistance levels of gonococci across Europe

September 2, 2016
In 2014, the susceptibility of gonococci to two of the recommended antibiotics for gonorrhoea treatment has shown signs of improvement, according to results from the European Gonococcal Antimicrobial Surveillance Programme ...

New drugs needed against gonorrhoea: UN

July 7, 2017
New drugs are urgently needed to treat gonorrhoea, a sexually-transmitted disease threatening to veer out of control as it develops resistance to existing antibiotics, the UN's health agency said Friday.

Discovery uncovers clue to disarm gonorrhea superbug

March 30, 2018
Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhoea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV ...

Push to control gonorrhoea as resistance threat looms

December 15, 2017
Australia's rising number of gonorrhoea cases has been described as a potential 'perfect storm', with the emergence of extensively drug resistant strains overseas.

Recommended for you

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

Study traces hospital-acquired bloodstream infections to patients' own bodies

October 15, 2018
The most common source of a bloodstream infection acquired during a hospital stay is not a nurse's or doctor's dirty hands, or another patient's sneeze or visitor's cough, but the patient's own gut, Stanford University School ...

Polio: Environmental monitoring will be key as world reaches global eradication

October 15, 2018
Robust environmental monitoring should be used as the world approaches global eradication of polio, say University of Michigan researchers who recently studied the epidemiology of the 2013 silent polio outbreak in Rahat, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.